Table 1 Clinical symptoms & quality of life evaluations
Global Quality of Life | ||||||||
Test (Abbreviation) | Short-Form Health survey (SF-36) | Visual-Analog-Scale on Quality of Life (VAS-QoL) | ||||||
Purpose | Global QoL assessment on the physiological and mental domain | Subjective global quality of life assessment in relation to the intracranial hypotension symptoms | ||||||
No. Of questions | 36 | 1 | ||||||
Recall period | Current and past four weeks | Current | ||||||
Scoring system | 0-100 (higher score better QoL) | 0-100 (higher score better QoL) | ||||||
Headache related Quality of Life | ||||||||
Test (Abbreviation) | Headache Impact Test (HIT-6) | Migraine specific Quality of Life Questionnaire (MSQ) | Migraine disability assessment (MIDAS) | |||||
Purpose | Impact headache on ability to function (job, school, home, social) | How migraines affect and/or limit daily function across three domains | Functional impact of migraine and headache on working life | |||||
No. Of questions | 6 | 14 | 5 | |||||
Recall period | Lifetime & past 4 weeks | Past 4 weeks | Past three months | |||||
Scoring system | 36–78 (higher score lower QoL) | 0-100 mean score of: RR – perceived limitations, PR – activities prevented by migraine, EF – migraine associated emotions), with higher score, better QoL | Grade I-IV (higher grade, lower QoL) | |||||
Headache frequency and intensity | ||||||||
Test (Abbreviation) | Visual-Analog-Scale of headache intensity (VAS-HI) | The amount of monthly headache days (MHD) | ||||||
Purpose | Subjective perception of the headache’s intensity | Objective count of the amount of headache days per month | ||||||
No. Of questions | 1 | 1 | ||||||
Recall period | current | 1 month | ||||||
Scoring system | 0-100 (higher score, more severe pain) | 0–30 (higher score, more days) | ||||||
Audio-vestibular symptoms | ||||||||
Test (Abbreviation) | Dizziness Handicap Inventory (DHI) | Tinnitus Handicap Inventory (THI) | Speech Spatial & Qualities of hearing Scale (15iSSQ) | |||||
Purpose | Evaluation of self-perceived handicap through dizziness. | Identification, quantification and evaluation of difficulties following tinnitus | Screening of spatial hearing and speech understanding ability in adults | |||||
No. Of questions | 25 | 25 | 15 | |||||
Recall period | Current | Current | Current | |||||
Scoring system | 0-100 (higher score, more dizziness) | 0-100 (higher score, stronger tinnitus) | 0–10 (higher score, less hearing disability) | |||||
Psychological symptoms | ||||||||
Test (Abbreviation) | Patient Health Questionnaire-9 (PHQ9) | General Anxiety Disorder (GAD-7) | Hospital Anxiety and Depression Scale (HAD) | Suicidal Ideation attributes scale (SIDAS) | ||||
Purpose | Evaluation of depression symptoms | Assessment of General Anxiety Disorder | Presence and severity of anxiety and depression symptoms in medical settings | Quantification of frequency and severity of suicidal ideation | ||||
No. Of questions | 9 | 7 | 0–21 per condition | 5 | ||||
Recall period | Past two weeks | Past two weeks | Past week | Past Months | ||||
Scoring system | 0–27 (higher score less favorable) | 0–21 (higher score less favorable) | 0–21 (higher score less favorable) | 0–50 (higher score less favorable) | ||||
Spiritual well-being | ||||||||
Test (Abbreviation) | Functional Assessment of Chronic Illness Therapy on Spiritual Well-Being (FACITsp12) | |||||||
Purpose | Evaluation of spiritual well-being in patients receiving treatment for chronic conditions | |||||||
No. Of questions | 12 | |||||||
Recall period | Past week | |||||||
Scoring system | 0–48 (higher score more favorable) | |||||||